Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Chabot et al v. Walgreens Boots Alliance, Inc. et al
Case Number:
1:18-cv-02118
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Buchanan Ingersoll
- Coren & Ress
- Fisher & Phillips
- Kaufman, Coren & Ress
- Robbins Geller
- Saxton & Stump
- Schneider Wallace
- Schneider Wallace Cottrell Konecky LLP
- Weil Gotshal
Companies
Sectors & Industries:
-
February 09, 2024
Rite Aid Investors' Attys Get $58M As Walgreens Deal OK'd
Counsel representing a class of Rite Aid investors will take home nearly $58 million in attorney fees after a Pennsylvania federal judge granted final approval to the $192.5 million deal resolving claims that Walgreens' executives lied about the likelihood of an ultimately unsuccessful merger between the two drugstore chains.
-
October 18, 2023
Rite Aid Investors, Walgreens Ink $192M Deal In Merger Row
A class of Rite Aid investors said Wednesday that Walgreens Boots Alliance has agreed to pay $192.5 million to end allegations in Pennsylvania federal court claiming that Walgreens' executives lied about the likelihood of an ultimately unsuccessful merger between the two drugstore chains.
-
April 03, 2023
Rite Aid Investors, Walgreens Can't Slim Or Toss Merger Suit
Walgreens Boots Alliance and the Rite Aid investors suing them over the drugstore chains' failed merger should probably be in settlement talks, a Pennsylvania federal judge hinted as he refused to toss or narrow the litigation.
-
January 25, 2022
Rite Aid Investors, Walgreens Ask To Slim Or Toss Merger Suit
Rite Aid investors and executives at Walgreens Boots Alliance Inc. both think enough facts are on their side to toss out or narrow a lawsuit over whether the executives' claims about the likelihood of an ultimately unsuccessful merger between the pharmacy giants artificially inflated Rite Aid stock.
-
June 07, 2021
Weil Overdid Merger Docs' Redactions, Rite Aid Investors Say
Weil Gotshal & Manges LLP excessively redacted large swaths of its communications with Walgreens executives when turning over documents to Rite Aid investors suing over the companies' failed merger, an attorney for the investors told a Pennsylvania federal magistrate Monday.
-
March 01, 2021
Weil Must Turn Over Walgreens-Rite Aid Merger Documents
Weil Gotshal & Manges LLP must turn over documents concerning the firm's communications with Walgreens and two of its executives over the company's failed merger with Rite Aid, a Pennsylvania federal judge has ruled in a class action alleging that the pharmacy chain misrepresented that the deal would clear the Federal Trade Commission.
-
January 21, 2020
Rite Aid Investors Challenging Walgreens Merger Win Cert.
Investors who lost money on Rite Aid stock during the company's failed merger with Walgreens received class certification Tuesday from a Pennsylvania federal judge, allowing them to level a suit against Walgreens and two of its executives over statements that supposedly inflated Rite Aid's value until the merger collapsed.
-
July 29, 2019
Rite Aid Investors Seek Cert. In Failed Walgreens Merger Suit
Three Rite Aid Corp. investors who lost stock value during a failed merger with Walgreens Boots Alliance Inc. have asked a Pennsylvania federal court to certify a class action accusing the companies' executives of making false statements that misrepresented the likelihood that regulators would have approved the merger.